Life Healthcare Group Holdings Limited/ADR
Life Healthcare Group Holdings Limited/ADR is a Healthcare company operating in Medical Care Facilities with a $901.5M market cap.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks LTGHY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LTGHY.
$ curl https://api.spokenalpha.com/v1/companies/LTGHYFAQ
Spoken Alpha indexes LTGHY's earnings call transcripts at https://spokenalpha.com/companies/LTGHY. Each call links to attributed speakers and parsed analyst Q&A. Life Healthcare Group Holdings Limited/ADR's own investor relations page is at https://www.lifehealthcare.co.za/investor-relations.
Life Healthcare Group Holdings Limited/ADR (LTGHY) operates in the Healthcare sector (Medical Care Facilities industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.84 | $2.61 | +47.1% | -1.6% | +1.0% |
| Q4 FY2026 | $4.13 | $2.81 | +46.8% | +3.9% | +5.5% |
| Q3 FY2026 | $3.72 | $2.69 | +38.2% | +8.8% | +10.7% |
| Q2 FY2026 | $3.97 | $2.77 | +43.4% | +3.8% | +0.9% |
| Q1 FY2025 | $3.78 | $2.78 | +36.1% | +5.4% | +5.8% |
| Q4 FY2025 |
| $3.88 |
| $2.85 |
| +36.2% |
| -1.7% |
| 0.0% |
| Q3 FY2025 | $3.85 | $2.67 | +44.3% | +9.7% | +8.9% |
| Q2 FY2025 | $3.92 | $2.84 | +38.1% | -1.5% | -1.0% |
| Q1 FY2024 | $3.85 | $2.89 | +33.3% | +9.9% | +12.4% |
| Q4 FY2024 | $3.77 | $2.74 | +37.6% | +5.7% | +6.0% |